Maternal-fetal transport kinetics of methotrexate in perfused human placenta: In vitro study

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 20, Issue 5, 2007, Pages 411-418

  Al Saleh, Eyad ^a   Al Harmi, Jehad ^a   Al Rashdan, Ibrahim ^a   Al Shammari, Majed ^a   Nandakumaran, Moorkath ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

Anti cancer drugs; Antipyrine; In vitro perfusion; Methotrexate; Placental transport

Indexed keywords

METHOTREXATE; PHENAZONE;

ADULT; AREA UNDER THE CURVE; ARTERIAL CIRCULATION; ARTICLE; CLINICAL TRIAL; DRUG ABSORPTION; DRUG CLEARANCE; DRUG RESPONSE; DRUG TRANSPORT; FEMALE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; LIQUID CHROMATOGRAPHY; NEWBORN; PLACENTA PERFUSION; PLACENTAL TRANSFER; PRIORITY JOURNAL; SPECTROPHOTOMETRY; STUDENT T TEST; TRANSPORT KINETICS;

ABSORPTION; ADULT; FEMALE; HUMANS; MATERNAL-FETAL EXCHANGE; METHOTREXATE; PERFUSION; PREGNANCY;

EID: 34547673129     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.1080/14767050701288218     Document Type: Article

References (47)

1. Winter ME. Methotrexate. In: Winter ME, editor. Basal clinical pharmacokinetics. Second ed. Spokane, WA: Applied Therapeutics; 1988. pp 199-217.
2. Crom WR, Evans WE. Methotrexate. In: Evans WE, Schentag JJ, Jusko WJ, editors. Applied pharmacokinetics: Principles of therapeutic drug monitoring. Third ed. Spokane, WA: Applied Therapeutics; 1992. pp 29-43.
3. Orlando L, Cardillo A, Rocca A, Balduzzi A, Ghisini R, Perozzotti G, Goldhirsch A, D'Alessandro C, Cinieri S, Preda L, et al. Prolonged clinical benefit with metronomic chemotherapy in patients with metastatic breast cancer. Anticancer Drugs 2006;17:961-967.
4. Pels H, Schlegel U. Primary central nervous system lymphoma. Curr Treat Options Neurol 2006;8:346-357.
5. Franklin JL, Finlay J. Leukemias and lymphomas: Treatment and prophylaxis of the central nervous system. Curr Treat Options Neurol 2006;8:335-345.
6. Nakayama N, Koizumi W, Tanabe S, Sasaki T, Saigenji K. A phase II study of combined chemotherapy with methotrexate, 5-fluorouracil and low-dose cisplatin (MFP) for histologically diffuse-type advanced and recurrent gastric cancer (KDOG9501). Gastric Cancer 2006;9:185-191.
7. Shigehara K, Kitagawa Y, Nakashima T, Shimamura M. Squamous cell carcinoma of the bladder: A patient treated successfully with a new combined chemotherapy regimen, intraarterial nedaplatin and pirarubicin plus intravenous methotrexate and vincristine. Int J Clin Oncol 2006;11:329-331.
8. Nash P. Alefacept plus methotrexate for psoriatic arthritis. Nat Clin Pract Rheumatol 2006;2:470-471.
9. Gray OM,McDonnell GV, Forbes RB. A systematic review of oral methotrexate for multiple sclerosis. Mult Scler 2006;12:507-510.
10. McNeish IA, Strickland S, Holden L, Rustin GJ, Foskett M, Seckl MJ, Newlands ES. Low-risk persistent gestational trophoblastic disease: Outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000. J Clin Oncol 2002;20:1838-1844.
11. Bannwarth B, Labat L, Moride Y, Schaeverbeke T. Methotrexate in rheumatoid arthritis. Drugs 1994;47:25-50.
12. Alshimmiri MM, Al-Saleh E, Al-Harmi JA, Alsalili MB, Adwani AA, Ibrahim ME. Treatment of ectopic pregnancy with a single intramuscular dose of methotrexate. Arch Gynecol Obstet 2003;268:181-183.
13. Periti E, Comparetto C, Villanucci A, Coccia ME, Tavella K, Amunni G. The use of intravenous methotrexate in the treatment of ectopic pregnancy. J Chemother 2004;16:211-215.
14. Dalkalitsis N, Stefos T, Kaponis A, Tsanadis G, Paschopoulos M, Dousias V. Reproductive outcome in patients treated by oral methotrexate or laparoscopic salpingotomy for the management of tubal ectopic pregnancy. Clin Exp Obstet Gynecol 2006;33:90-92.
15. Warkany J. Teratogenicity of folic acid antagonists. Cancer Bull 1981;33:76-77.
16. Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation. Fifth ed. Baltimore, USA: Williams and Wilkins; 1998. pp 702-706.
17. Buckley LM, Bullaboy CA, Leichtman L, Marquez M. Multiple congenital anomalies associated with weekly low-dose methotrexate treatment of the mother. Arthritis Rheum 1997;40:971-973.
18. Schleuning M, Clemm C. Chromosomal aberrations in a newborn whose mother received cytotoxic treatment during pregnancy. New Engl J Med1987;317:1666-1667.
19. Milunsky A, Graef JW, Gaynor MF. Methotrexate-induced congenital malformations. J Pediatr 1968;72:790-795.
20. Ostensen M, Hartmann H, Salvensen K. Low dose weekly methotrexate in early pregnancy. A case series and review of the literature. J Rheumatol 2000;27:1872-1875.
21. Rustin GJ, Booth M, Dent J, Salt S, Rustin F, Bagshawe KD. Pregnancy after cytotoxic chemotherapy for gestational trophoblastic tumours. Br Med J 1984;288:103-106.
22. Nandakumaran M, Gardey C, Challier JC, Panigel M, Olive G. Transfer of salbutamol in the human placenta in vitro. Dev Pharmacol Ther 1981;3:88-98.
23. Nandakumaran M, Makhseed M, al-Rayyes S, al-Yatama M, Devarajan L, Sugathan T. Kinetics of palmitic acid transport in insulin-dependent diabetic pregnancies: In vitro study. Pediatr Int 2000;42:296-301.
24. Nandakumaran M, Makhseed M, Al-Rayyes S, Akanji AO, Sugathan TN. Effect of insulin on transport kinetics of α-aminoisobutyric acid in the perfused human placental lobule in vitro. Pediatr Int 2001;43:581-586.
25. Schneider H, Proegler M, Sodha R, Dancis J. Asymmetrical transfer of α-aminoisobutyric acid (AIB), leucine and lysine across the in vitro perfused human placenta. Placenta 1985;8:141-151.
26. Nandakumaran M, Sugathan TN. Assessment of transport dynamics in the perfused human placental lobule. Med Principles Pract 1992-93;3:219-222.
27. Fabre G, Cano JP, Iliadis A, Carcassonne Y, Favre R, Gilli R, Catalin J. Assay of methotrexate and 7-hydroxymethotrexate by gradient-elution high performance liquid chromatography and its application in a high dose pharmacokinetic study. J Pharm Biomed Anal 1984;2:61-72.
28. Brodie BB, Axelrod J, Soberman R, Levy BB. The estimation of antipyrine in biological materials. J Biol Chem 1949;179:25-29.
29. Rey E, Nandakumaran M, Richard MO, Loose JP, D'Athis P, Saint Maurice C, Olive G. Pharmacokinetics of flunitrazepam after single rectal administration in children. Dev Pharmacol Ther 1984;7:206-212.
30. Nandakumaran M, Eldeen AS. Transfer of cyclosporine A in the perfused human placenta. Dev Pharmacol Ther 1990;15:101-105.
31. Challier JC, Guerre- Millo M, Richard MO, Schneider H, Panigel M, Olive G. Transfert et echange d'antipyrine dans le lobule placentaire humain perfuse in vitro. Ann Biol Anim Biochim Biophys 1977;17:1107-1115.
32. Schneider H, Panigel M, Dancis J. Transfer across the perfused human placenta of antipyrine, sodium and leucine. Am J Obstet Gynecol 1972;114:822-828.
33. Battaglia FC, Meschia G, Makowski EL. Comparison of in vitro and in vivo placental permeability measurements. Am J Physiol 1969;216:1590-1594.
34. Seeds AE, Schruefer JJ, Reinhardt JA, Garlid KD. Diffusion mechanism across human placental tissue. Gynecol Invest 1973;4:31-37.
35. Moya F, Thorndike V. Passage of drugs across the placenta. Am J Obstet Gynecol 1962;84:1778-1798.
36. Nandakumaran M, Gardey C, Challier JC, Rey E, Lambrey B, Olive G. Transfer of salbutamol, ritodrine and norepinephrine in the human placenta. In: Mathieu H, Olive G, Pontonnier G, editors. Pharmacologie du developpement. Paris: INSERM; 1979. pp 255-264.
37. Nandakumaran M, Olive G. Placental transfer of drugs: A mini-review. In: Roy Chowdhury NN, Roy Chowdhury J, editors. Recent trends in perinatology. Calcutta, India: Nachiketa Publ; 1983. pp 141-178.
38. Guerre-Millo M, Rey E, Challier JC, D'Athis P, Barrier G, Turquais JM, Sureau C, Olive G. Etude du passage de trois benzodiazepines de la mere au fetus dans le lobule placentaire humain perfuse in vitro. In: Pontonnier G, Cros J, editors. Pharmacologie perinatale. Paris: INSERM; 1977. pp 44-45.
39. Kumagai T, Inoue T, Mihara Y, Ebina K, Yokota K. Influence of drugs on the oxygen uptake rate and biosorption of activated sludge. Biol Pharm Bull 2006;29:183-186.
40. Nandakumaran M, Challier JC, Rey E, Richard MO, Olive G. In vitro transfer of six benzamides in the human placenta. Dev Pharmacol Ther 1984;7:60-66.
41. Brock S, Jennings HR. Fetal acute encephalomyelitis after a single dose of intrathecal methotrexate. Pharmacotherapy 2004;24:673-676.
42. Valik D, Sterba J, Bajciova V, Demlova R. Severe encephalopathy induced by the first but not the second course of high dose methotrexate mirrored by plasma homocysteine evaluations and preceded by extreme differences in pretreatment plasma folate. Oncology 2005;69:269-272.
43. Khan F, Everard J, Ahmed S, Coleman RE, Aitken M, Hancock BW. Low-risk persistent gestational trophoblastic disease treated with low-dose methotrexate: Efficacy, acute and long-term effects. Br J Cancer 2003;89:2197-2101.
44. Troche G, Sacquin P, Achkar A, Korach JM, Laaban JP, Gajdos P. Severe methotrexate poisoning. Presse Med 1991;20:1724-1727.
45. Chatham WW, Morgan SL, Alarcon GS. Renal failure: A risk factor for methotrexate toxicity. Arthritis Rheum 2000;43:1185-1186.
46. Widemann BC, Hetherington ML, Murphy RF, Balis FM, Adamson PC. Carboxypeptidase-G2 rescue in a patient with high dose methotrexate-induced nephrotoxicity. Cancer 1995;76:521-526.
47. Sieber SM, Adamson RH. Toxicity of antineoplastic agents in man: Chromosomal aberrations, antifertility effects, congenital malformations and carcinogenic potential. Adv Cancer Res 1975;22:57-155.